Rosie O'Donnell made no secret of her weight loss journey on Mounjaro — the medication that has become one of the most talked about pharmaceutical developments in recent years for its dramatic results. She lost a significant amount of weight and spoke openly about it.
What she did not anticipate — and what cosmetic experts are now pointing out publicly — is what rapid weight loss does to the face.
The phenomenon has been widely documented enough that it now has its own name — Mounjaro face, or more broadly ozempic face — referring to the hollowing, sagging, and jowl formation that occurs when facial fat disappears faster than the skin can adapt to the change. The face ages visibly and rapidly in ways that the rest of the body's transformation does not prepare anyone for.
Rosie had a facelift costing $90,000 before the weight loss. The procedure was designed to lift, tighten and restore a more youthful facial structure. Cosmetic experts looking at recent photographs of her say the results of that facelift are now being significantly undermined by the facial volume loss that Mounjaro has caused.
The skin that was lifted has less fat underneath it to maintain the result. The jowling that the procedure addressed has begun to reappear not because the surgery failed but because the structural foundation it relied on has changed.
It is a dilemma that doctors are increasingly encountering — patients who have invested heavily in cosmetic procedures and then lost significant weight through medication, only to find the two do not complement each other the way they hoped.
Rosie O'Donnell looks different. The $90,000 facelift is still there. So is the Mounjaro face.